Edition:
United States

Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.39USD
26 Jul 2016
Change (% chg)

$-0.03 (-0.36%)
Prev Close
$8.42
Open
$8.41
Day's High
$8.55
Day's Low
$8.37
Volume
852,125
Avg. Vol
1,424,810
52-wk High
$10.95
52-wk Low
$5.57

ACHN.O

Chart for ACHN.O

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's primary business is to discover, develop and commercialize small molecule therapeutics for the treatment of infectious diseases and immune system disorders. The Company is focused on its complement inhibitor platform, directed at advancing small... (more)

Overall

Beta: 2.27
Market Cap(Mil.): $1,150.51
Shares Outstanding(Mil.): 136.64
Dividend: --
Yield (%): --

Financials

  ACHN.O Industry Sector
P/E (TTM): -- 41.28 37.71
EPS (TTM): -0.07 -- --
ROI: -1.09 -9.20 14.43
ROE: -1.09 -9.24 15.61

BRIEF-Achillion reports Q1 loss per share $0.13

* Achillion reports first quarter 2016 financial results and provides update on clinical programs

May 03 2016

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $36.83 +0.05
Johnson & Johnson (JNJ.N) $125.15 +0.26
Novartis AG (NOVN.S) CHF82.50 +0.30
Merck & Co., Inc. (MRK.N) $58.36 -0.20
Roche Holding Ltd. (ROG.S) CHF250.30 +1.50
Roche Holding Ltd. (RO.S) CHF251.25 +1.25
Abbott Laboratories (ABT.N) $43.60 +0.19
AstraZeneca plc (AZN.L) 4,638.50p -15.00
GlaxoSmithKline plc (GSK.L) 1,667.00p +10.00
Bristol-Myers Squibb Co (BMY.N) $75.06 -0.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.